Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D

15 participants · First posted Apr 18, 2019

Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)

10 participants · First posted Jul 2, 2026

Single Ascending and Multiple Ascending Dose Study of LCA-0061

72 participants · First posted Jul 14, 2026

LCA-60

LCA-AAV7

LCA-10

Rca

Belgium

SANGIORGI LUCA

Italy

CHRYSEA LABS, LDA

Portugal

Opus Genetics Advances LCA5 Gene Therapy Program with First Pediatric Patient Dosing and Promising Adult Data

Opus Genetics to Present 6-Month Data on OPGx-LCA5 Gene Therapy for LCA5-Associated Inherited Retinal Disease

Atsena Therapeutics and Nippon Shinyaku Partner to Advance Gene Therapy for LCA1